
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (05): 639-648.DOI: 10.12114/j.issn.1007-9572.2024.0295
Special Issue: 阿尔茨海默病最新文章合辑; 中医最新文章合辑
• Review & Perspectives • Previous Articles
Received:2024-07-10
Revised:2024-08-25
Published:2025-02-15
Online:2024-11-25
Contact:
LIU Bin
通讯作者:
刘斌
作者简介:作者贡献:
裴金英提出研究命题,进行文章的构思与撰写;宋金洲、马到丰进行文献的检索与收集;罗孝廷、董晓红、丛树园进行论文修订;刘斌负责文章的质量控制及审校,并对文章整体负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0295
| 有效成分 | 模型 | 剂量 | 靶点 |
|---|---|---|---|
| 红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
| Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
| 连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
| 芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
| 淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
| 何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
| 远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
| 细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
| 银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
| Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
| 小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
| 番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
| 旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
| 圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
| 表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
| 仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
| 大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
| 麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
| 茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
Table 1 Experimental study on the treatment of Alzheimer's disease with effective ingredients of traditional Chinese medicine
| 有效成分 | 模型 | 剂量 | 靶点 |
|---|---|---|---|
| 红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
| Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
| 连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
| 芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
| 淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
| 何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
| 远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
| 细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
| 银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
| Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
| 小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
| 番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
| 旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
| 圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
| 表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
| 仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
| 大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
| 麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
| 茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
李燕新,吕占云,李维,等. 铁死亡相关蛋白在AD小鼠海马中的表达[J]. 中国神经精神疾病杂志,2018,44(12):727-731. DOI:10.3969/j.issn.1002-0152.2018.12.008.
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
樊赟,窦润鹏,胡久略,等. 茯苓酸通过Nrf2/SLC7A11/GPX4信号通路调控铁死亡改善阿尔茨海默病大鼠认知障碍的研究[J]. 中国全科医学,2024,27(2):177-183. DOI:10.12114/j.issn.1007-9572.2023.0326.
|
| [79] |
|
| [80] |
刘珊,贺小平,赵炎,等. 淫黄葛合剂对APP/PS1 HAMP-/-小鼠认知功能和铁死亡氨基酸代谢通路的影响[J]. 中国病理生理杂志,2024,40(3):502-510. DOI:10.3969/j.issn.1000-4718.2024.03.014.
|
| [81] |
|
| [1] | FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063. |
| [2] | LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949. |
| [3] | CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807. |
| [4] | CHEN Yiping, ZHANG Jianmei, LI Yanhu, LI Rui, ZHANG Ruiping, YANG Ping. Advances in the Diagnosis and Treatment of Post-COVID-19 Condition of Myocardial Injury [J]. Chinese General Practice, 2026, 29(18): 2585-2592. |
| [5] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [6] | ZHANG Mingyue, HOU Yan. Research Progress of Exhaled Nitric Oxide and Alveolar Nitric Oxide in Interstitial Lung Diseases [J]. Chinese General Practice, 2026, 29(18): 2571-2576. |
| [7] | MA Xiaoyu, MA Xiaomei, WU Guozhi, ZHENG Ya, GUO Qinghong. Research Progress of Neutrophil Extracellular Traps in Gastric Cancer [J]. Chinese General Practice, 2026, 29(17): 2425-2432. |
| [8] | LI Jiawei, GE Aoqi, GAO Xinyi, LI Juanjuan, YUAN Beibei. The Concept, Connotation, and Pathways of the Integration of Medical Care and Preventive Services in China: a Systematic Review [J]. Chinese General Practice, 2026, 29(16): 2156-2166. |
| [9] | WANG Yang, JIN Hua, YANG Sen, YANG Hui, YU Dehua. Reconfiguring the Functional Features of Primary Care in a Non-gatekeeping Context: a 15-Year Mixed-methods Systematic Review from China [J]. Chinese General Practice, 2026, 29(16): 2140-2155. |
| [10] | ZOU Jian, LI Wanping, GE Handa, JIN Zhe, RUFEINA· Tuerxun, LI Juan, WEI Anhua, FENG Da. Study on Potentially Inappropriate Medication Use among the Community Elderly Patients in Hubei Province [J]. Chinese General Practice, 2026, 29(13): 1759-1765. |
| [11] | ZHANG Qiang, ZHAO Wenxia, WANG Ziyi, YAN Le, LIANG Haowei, WANG Jinfan, FANG Jinhua, LU Cuncun. Interpretation of the Reporting Guideline for Systematic Reviews of Outcome Measurement Instruments (PRISMA-COSMIN for OMIs 2024) [J]. Chinese General Practice, 2026, 29(13): 1766-1775. |
| [12] | YE Xinying, YIN Ankang, LIU Dingling, LYU Xiang, WANG Yi. The Development of General Practice Department in General Hospitals under the DIP Payment Model [J]. Chinese General Practice, 2026, 29(11): 1378-1384. |
| [13] | SHI Yufeng, LU Chenxia, LYU Anqi, LI Xiaodong. Research Progress on the Relationship between Veillonella and Liver Diseases Based on the Theory of Intestinal-hepatic Axis [J]. Chinese General Practice, 2026, 29(11): 1488-1496. |
| [14] | SUN Yuchen, SHI Yaxin, SHI Wei. Advancements in the Treatment of Endometrial Hypofunction Diseases Using Menstrual Blood-derived Endometrium Stem Cells Combined with Traditional Chinese Medicine for Tonifying Kidney and Activating Blood in Regenerative Medicine [J]. Chinese General Practice, 2026, 29(11): 1481-1487. |
| [15] | WANG Gaoming, WANG Minghang, YANG Jiang, MENG Yuanyuan, ZHAO Di, DONG Xiaosheng. Systematic Evaluation and Reflection on the Quality of Bronchial Asthma Guidelines in China [J]. Chinese General Practice, 2026, 29(10): 1239-1245. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||